Actinium Pharmaceuticals, Inc. (ATNM)
NYSEAMERICAN: ATNM · Real-Time Price · USD
1.610
-0.020 (-1.23%)
Aug 1, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021
Period Ending
Dec '23 Dec '22 Dec '21
Radiotherapies
81.00K
Log In
Log In
Radiotherapies Growth
-92.14%
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021
Period Ending
Dec '23 Dec '22 Dec '21
United States
81.00K
Log In
Log In
United States Growth
-92.14%
Log In
Log In